LC vs XERS · P/E 28, $1.43B cap vs rev $175.2M
LendingClub Corp (LC) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
LendingClub Corp (LC) is a banks - regional company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
LC does not have a complete income-statement cache yet.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
LC currently screens at market cap $1.43B and trailing P/E 28.4. XERS currently screens at market cap $760.7M.
Not investment advice. Open the LC and XERS stock pages for the full models.
Not investment advice.